Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 16.65% vs 2.24% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 1.09% vs -18.77% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is -23.13% vs 29.81% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is -13.32% vs -21.16% in Mar 2025
Compare Profit and Loss Results of Anuh Pharma
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
771.00
188.00
583.00
310.11%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
771.00
188.00
583.00
310.11%
Expenditure (Ex Depriciation)
Stock Adjustments
10.00
1.00
9.00
900.00%
Raw Materials Consumed
589.00
87.00
502.00
577.01%
Power & Fuel Cost
13.00
2.00
11.00
550.00%
Employee Cost
26.00
12.00
14.00
116.67%
Operating Expenses
40.00
6.00
34.00
566.67%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
10.00
30.00
-20.00
-66.67%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
11.00
6.00
5.00
83.33%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
709.00
155.00
554.00
357.42%
Operating Profit (PBDIT) excl Other Income
62.00
33.00
29.00
87.88%
Other Income
4.00
13.00
-9.00
-69.23%
Operating Profit (PBDIT)
66.00
47.00
19.00
40.43%
Interest
0.00
3.00
-3.00
-100.00%
Profit before Depriciation and Tax
65.00
43.00
22.00
51.16%
Depreciation
11.00
2.00
9.00
450.00%
Profit Before Taxation & Exceptional Items
54.00
41.00
13.00
31.71%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
54.00
41.00
13.00
31.71%
Provision for Tax
13.00
9.00
4.00
44.44%
Profit After Tax
41.00
32.00
9.00
28.12%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
184.00
162.00
22.00
13.58%
Profit Available for appropriations
225.00
195.00
30.00
15.38%
Appropriations
225.00
195.00
30.00
15.38%
Equity Dividend (%)
30%
0%
30.00
Earnings Per Share
4.1
9.57
-5.47
-57.16%
Profit And Loss - Net Sales
Net Sales 771.66 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 16.65% vs 2.24% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 62.20 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 1.09% vs -18.77% in Mar 2025
Profit And Loss - Interest
Interest 0.95 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -23.13% vs 29.81% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 41.05 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -13.32% vs -21.16% in Mar 2025
